Tumor necrosis factor–α, interleukin-1, and endotoxin stimulate the expression of vascular endothelial cell (EC) adhesion molecules. Here we describe a novel pathway of adhesion molecule induction that is independent of exogenous factors, but which is dependent on integrin signaling and cell–cell interactions. Cells plated onto gelatin, fibronectin, collagen or fibrinogen, or anti-integrin antibodies, expressed increased amounts of E-selectin, vascular cell adhesion molecule–1, and intercellular adhesion molecule–1. In contrast, ECs failed to express E-selectin when plated on poly-l-lysine or when plated on fibrinogen in the presence of attachment-inhibiting, cyclic Arg-Gly-Asp peptides. The duration and magnitude of adhesion molecule expression was dependent on EC density. Induction of E-selectin on ECs plated at confluent density was transient and returned to basal levels by 15 h after plating when only 7 ± 2% (n = 5) of cells were positive. In contrast, cells plated at low density displayed a 17-fold greater expression of E-selectin than did high density ECs with 57 ± 4% (n = 5) positive for E-selectin expression 15 h after plating, and significant expression still evident 72 h after plating. The confluency-dependent inhibition of expression of E-selectin was at least partly mediated through the cell junctional protein, platelet/endothelial cell adhesion molecule–1 (PECAM-1). Antibodies against PECAM-1, but not against VE-cadherin, increased E-selectin expression on confluent ECs. Co– culture of subconfluent ECs with PECAM-1– coated beads or with L cells transfected with full-length PECAM-1 or with a cytoplasmic truncation PECAM-1 mutant, inhibited E-selectin expression. In contrast, untransfected L cells or L cells transfected with an adhesion-defective domain 2 deletion PECAM-1 mutant failed to regulate E-selectin expression. In an in vitro model of wounding the wound front displayed an increase in the number of E-selectin–expressing cells, and also an increase in the intensity of expression of E-selectin positive cells compared to the nonwounded monolayer. Thus we propose that the EC junction, and in particular, the junctional molecule PECAM-1, is a powerful regulator of endothelial adhesiveness.
Skip Nav Destination
Article navigation
6 October 1997
Article|
October 06 1997
Novel Cytokine-independent Induction of Endothelial Adhesion Molecules Regulated by Platelet/Endothelial Cell Adhesion Molecule (CD31)
Marek Litwin,
Marek Litwin
*Division of Human Immunology, Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide, South Australia, 5000 Australia; ‡Vascular Biology Laboratory, Baker Medical Research Institute, Prahran Victoria 3181; and §Director of Lung Research, Pulmonary and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-4283
Search for other works by this author on:
Katherine Clark,
Katherine Clark
*Division of Human Immunology, Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide, South Australia, 5000 Australia; ‡Vascular Biology Laboratory, Baker Medical Research Institute, Prahran Victoria 3181; and §Director of Lung Research, Pulmonary and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-4283
Search for other works by this author on:
Leanne Noack,
Leanne Noack
*Division of Human Immunology, Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide, South Australia, 5000 Australia; ‡Vascular Biology Laboratory, Baker Medical Research Institute, Prahran Victoria 3181; and §Director of Lung Research, Pulmonary and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-4283
Search for other works by this author on:
Jill Furze,
Jill Furze
*Division of Human Immunology, Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide, South Australia, 5000 Australia; ‡Vascular Biology Laboratory, Baker Medical Research Institute, Prahran Victoria 3181; and §Director of Lung Research, Pulmonary and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-4283
Search for other works by this author on:
Michael Berndt,
Michael Berndt
*Division of Human Immunology, Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide, South Australia, 5000 Australia; ‡Vascular Biology Laboratory, Baker Medical Research Institute, Prahran Victoria 3181; and §Director of Lung Research, Pulmonary and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-4283
Search for other works by this author on:
Steven Albelda,
Steven Albelda
*Division of Human Immunology, Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide, South Australia, 5000 Australia; ‡Vascular Biology Laboratory, Baker Medical Research Institute, Prahran Victoria 3181; and §Director of Lung Research, Pulmonary and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-4283
Search for other works by this author on:
Mathew Vadas,
Mathew Vadas
*Division of Human Immunology, Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide, South Australia, 5000 Australia; ‡Vascular Biology Laboratory, Baker Medical Research Institute, Prahran Victoria 3181; and §Director of Lung Research, Pulmonary and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-4283
Search for other works by this author on:
Jennifer Gamble
Jennifer Gamble
*Division of Human Immunology, Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide, South Australia, 5000 Australia; ‡Vascular Biology Laboratory, Baker Medical Research Institute, Prahran Victoria 3181; and §Director of Lung Research, Pulmonary and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-4283
Search for other works by this author on:
Marek Litwin
*Division of Human Immunology, Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide, South Australia, 5000 Australia; ‡Vascular Biology Laboratory, Baker Medical Research Institute, Prahran Victoria 3181; and §Director of Lung Research, Pulmonary and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-4283
Katherine Clark
*Division of Human Immunology, Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide, South Australia, 5000 Australia; ‡Vascular Biology Laboratory, Baker Medical Research Institute, Prahran Victoria 3181; and §Director of Lung Research, Pulmonary and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-4283
Leanne Noack
*Division of Human Immunology, Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide, South Australia, 5000 Australia; ‡Vascular Biology Laboratory, Baker Medical Research Institute, Prahran Victoria 3181; and §Director of Lung Research, Pulmonary and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-4283
Jill Furze
*Division of Human Immunology, Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide, South Australia, 5000 Australia; ‡Vascular Biology Laboratory, Baker Medical Research Institute, Prahran Victoria 3181; and §Director of Lung Research, Pulmonary and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-4283
Michael Berndt
*Division of Human Immunology, Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide, South Australia, 5000 Australia; ‡Vascular Biology Laboratory, Baker Medical Research Institute, Prahran Victoria 3181; and §Director of Lung Research, Pulmonary and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-4283
Steven Albelda
*Division of Human Immunology, Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide, South Australia, 5000 Australia; ‡Vascular Biology Laboratory, Baker Medical Research Institute, Prahran Victoria 3181; and §Director of Lung Research, Pulmonary and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-4283
Mathew Vadas
*Division of Human Immunology, Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide, South Australia, 5000 Australia; ‡Vascular Biology Laboratory, Baker Medical Research Institute, Prahran Victoria 3181; and §Director of Lung Research, Pulmonary and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-4283
Jennifer Gamble
*Division of Human Immunology, Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide, South Australia, 5000 Australia; ‡Vascular Biology Laboratory, Baker Medical Research Institute, Prahran Victoria 3181; and §Director of Lung Research, Pulmonary and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-4283
M. Vadas and J. Gamble contributed equally to this paper.
Address all correspondence to Jennifer Gamble, Division of Human Immunology, Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, P.O. Box 14, Rundle Mall, Adelaide, South Australia, 5000 Australia. Tel. 6188-232-4092. Fax: 6188-232-4092. e-mail: [email protected]
Received:
July 23 1996
Revision Received:
December 06 1996
Online ISSN: 1540-8140
Print ISSN: 0021-9525
1997
J Cell Biol (1997) 139 (1): 219–228.
Article history
Received:
July 23 1996
Revision Received:
December 06 1996
Citation
Marek Litwin, Katherine Clark, Leanne Noack, Jill Furze, Michael Berndt, Steven Albelda, Mathew Vadas, Jennifer Gamble; Novel Cytokine-independent Induction of Endothelial Adhesion Molecules Regulated by Platelet/Endothelial Cell Adhesion Molecule (CD31) . J Cell Biol 6 October 1997; 139 (1): 219–228. doi: https://doi.org/10.1083/jcb.139.1.219
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement